Medicine
NINTEDANIB 150 mg CIPLA
Key ingredient(s)
0 Mg
Nintedanib Esylate 150
Available forms & strengths
Request this medicine| Form | Strength | Pack | Route | Icon |
|---|---|---|---|---|
| CAPSULES | 150,0 mg | — | Oral |
|
Notes: SAHPRA secureId: CfDJ8L67LitnFgdOq0Uv0zyh2bregy2kw4jQTX2UKwiwUvv_T_ZXaoIvK5tbKSAF_xg9njZyvLCBk5axX0fdfTAIzsC1TEBUsk-RDbElYWatzfRu7XlbpZour1BwvfXUC6d1iQ | Reg: 56/26/0705.703 | AppNo: 560705.703 | RegDate: 2023/09/26 | Applicant: Cipla Medpro (Pty) Ltd | Status: Registered